Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Doyle

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Polymers|January 11, 2024
Elucidating the Role of Optical Activity of Polymers in Protein-Polymer InteractionsSamin Jahan, Catherine Doyle, Anupama Ghimire, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Adherence to CONSORT Guidelines and Reporting of the Determinants of External Validity in Clinical Oncology Randomized Controlled Trials: A Review of Trials Published in Four Major Journals between 2013 and 2015Sophie Audet, Catherine Doyle, Christopher Lemieux, et al.
Breast (Edinburgh, Scotland)|April 1, 2014
Evaluation of eligibility and recruitment in breast cancer clinical trialsJulie Lemieux, Geneviève Forget, Olyvia Brochu, et al.
Clinical Trials (London, England)|October 13, 2012
Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollmentMyriam Filion, Geneviève Forget, Olyvia Brochu, et al.
Microbiology Resource Announcements|November 13, 2020
Deeply Sequenced Infectious Clones of Key Cassava Begomovirus Isolates from CameroonJ Steen Hoyer, Vincent N Fondong, Mary M Dallas, et al.
Journal of Surgical Oncology|March 31, 2018
In response to: Long-term overall survival of patients diagnosed with pure tubular carcinoma of the breast might be affected by increased co-morbiditiesÉric Poirier, Christine Desbiens, Brigitte Poirier, et al.
Journal of Surgical Oncology|December 6, 2017
Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breastÉric Poirier, Christine Desbiens, Brigitte Poirier, et al.
The Annals of Pharmacotherapy|December 11, 2013
Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patientsEric Poirier, Christine Desbiens, Brigitte Poirier, et al.
Blood Cancer Journal|January 3, 2020
Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformationGeorge Yang, Matthew Mills, Youngchul Kim, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot StudyJulie Lemieux, Isabelle Côté, Martine Lemay, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Polymers|January 11, 2024
Elucidating the Role of Optical Activity of Polymers in Protein-Polymer InteractionsSamin Jahan, Catherine Doyle, Anupama Ghimire, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Adherence to CONSORT Guidelines and Reporting of the Determinants of External Validity in Clinical Oncology Randomized Controlled Trials: A Review of Trials Published in Four Major Journals between 2013 and 2015Sophie Audet, Catherine Doyle, Christopher Lemieux, et al.
Breast (Edinburgh, Scotland)|April 1, 2014
Evaluation of eligibility and recruitment in breast cancer clinical trialsJulie Lemieux, Geneviève Forget, Olyvia Brochu, et al.
Clinical Trials (London, England)|October 13, 2012
Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollmentMyriam Filion, Geneviève Forget, Olyvia Brochu, et al.
Microbiology Resource Announcements|November 13, 2020
Deeply Sequenced Infectious Clones of Key Cassava Begomovirus Isolates from CameroonJ Steen Hoyer, Vincent N Fondong, Mary M Dallas, et al.
Journal of Surgical Oncology|March 31, 2018
In response to: Long-term overall survival of patients diagnosed with pure tubular carcinoma of the breast might be affected by increased co-morbiditiesÉric Poirier, Christine Desbiens, Brigitte Poirier, et al.
Journal of Surgical Oncology|December 6, 2017
Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breastÉric Poirier, Christine Desbiens, Brigitte Poirier, et al.
The Annals of Pharmacotherapy|December 11, 2013
Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patientsEric Poirier, Christine Desbiens, Brigitte Poirier, et al.
Blood Cancer Journal|January 3, 2020
Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformationGeorge Yang, Matthew Mills, Youngchul Kim, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot StudyJulie Lemieux, Isabelle Côté, Martine Lemay, et al.
Pageof 3